Completed OBSERVATIONAL NCT01444456

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

Electronic Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia: An International Prospective Observational Study (eAQUA)

Sponsor: Amgen

Conditions Anemia Bladder Cancer Breast Cancer Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Prostate Cancer Renal Cancer Solid Tumors

Updated 8 times since 2017 Last updated: Feb 7, 2017 Started: Oct 31, 2011 Primary completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Anemia and Bladder Cancer, this trial is completed. The trial is conducted by Amgen and has accumulated 8 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — May 2017 [monthly]

Completed NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amgen

Data source: Amgen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalst, Belgium , Aix-en-Provence, France , Alba Iulia, Romania , Amiens, France , Amstelveen, Netherlands , Athens, Greece , Aubagne, France , Augsburg, Germany , Baia Mare, Romania , Bayonne, France and 94 more locations